An Indian lunch buffet seminar with and by Cadila Pharmaceuticals Ltd Medical Management
Pharmaceutical research in India provides a unique set of opportunities and challenges, and during this presentation, knowledge acquired from operating in India for more than sixty years, including recent regulatory development, will be condensed into a session where the audience is encouraged to have their questions addressed.
Cadila Pharmaceuticals is one of the largest pharmaceutical companies in India with a well-established track record within clinical development and putting products on the market in India. Initiation of clinical trials in India typically requires that the sponsor is willing, or even committed to market the product in India. In this aspect it is an advantage to work with a major local, and well know, brand as Cadila Pharmaceuticals. As a pharmaceutical company we have a fully integrated development facility, ranging from CMC, Pre-Clinical, Clinical all the way to commercial manufacturing, where wisdom is transferred from department to department. Although Cadila is not a CRO, we are open to make this highly efficient development machinery available to our Swedish collaborators on a flexible shared-risk basis.
In terms of the cost efficiency, Cadila can conduct a trial India at a 50 to 70 percent lower cost than in United States or European Union. Pre-clinical costs with Cadila are substantially less than those in the western world and it is possible to conduct both new drug discovery research and novel drug delivery system programs at competitive rates.
Challenges and opportunities put together, India is one of the best locations to place pharmaceutical research and development; working with a strong local partner will help leveraging advantages such as high patient enrolment rate, human resources, technical skills, reliable data quality and dynamic economic environment.
Registration @ email@example.com